BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27716850)

  • 21. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
    Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
    Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells.
    Sheard MA; Asgharzadeh S; Liu Y; Lin TY; Wu HW; Ji L; Groshen S; Lee DA; Seeger RC
    J Immunother; 2013 Jun; 36(5):319-29. PubMed ID: 23719242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baculovirus directly activates murine NK cells via TLR9.
    Moriyama T; Suzuki T; Chang MO; Kitajima M; Takaku H
    Cancer Gene Ther; 2017 Apr; 24(4):175-179. PubMed ID: 28186087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
    Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
    Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.
    Seidel D; Shibina A; Siebert N; Wels WS; Reynolds CP; Huebener N; Lode HN
    Cancer Immunol Immunother; 2015 May; 64(5):621-34. PubMed ID: 25711293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.
    Feng S; Madsen SH; Viller NN; Neutzsky-Wulff AV; Geisler C; Karlsson L; Söderström K
    Immunology; 2015 Jul; 145(3):367-79. PubMed ID: 25684021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-15 activated bovine natural killer cells express CD69 and produce interferon-γ.
    Lund H; Boysen P; Dean GA; Davis WC; Park KT; Storset AK
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):79-89. PubMed ID: 23021353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
    Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
    J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
    Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
    Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
    Jähn PS; Zänker KS; Schmitz J; Dzionek A
    Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
    Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
    J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo activation of CD56(+) immune cells that eradicate neuroblastoma.
    Rujkijyanont P; Chan WK; Eldridge PW; Lockey T; Holladay M; Rooney B; Davidoff AM; Leung W; Vong Q
    Cancer Res; 2013 Apr; 73(8):2608-18. PubMed ID: 23440424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
    Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
    Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
    Front Immunol; 2019; 10():2816. PubMed ID: 31849984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
    Li L; Yang J; Jiang Y; Tu J; Schust DJ
    Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
    Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
    EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
    Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
    Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcriptional regulator NAB2 reveals a two-step induction of TRAIL in activated plasmacytoid DCs.
    Balzarolo M; Karrich JJ; Engels S; Blom B; Medema JP; Wolkers MC
    Eur J Immunol; 2012 Nov; 42(11):3019-27. PubMed ID: 22806638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of anti-tumor immunity by tolerogenic dendritic cells.
    Chen L; Hasni MS; Jondal M; Yakimchuk K
    Autoimmunity; 2017 Sep; 50(6):370-376. PubMed ID: 28675711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.